Vanguard Personalized Indexing Management, LLC
Position in GMAB — Genmab A/S
CIK 1767306
OAKLAND, CA
Position in GMAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,537,144
-$731,399 QoQ
Shares Held
57,292
-22.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 81.92592334008239.ToString("F0")%
Shared 0.ToString("F0")%
None 18.074076659917615.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vanguard Personalized Indexing Management, LLC holds $87,929,796 across 143 Biotechnology names. GMAB ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,623 | $18,586,334 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,633 | $9,760,761 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,215 | $4,041,577 | |
| 4 | INCY |
Incyte Corp
|
32,067 | $3,018,146 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
132,661 | $2,679,752 | |
| 6 | ARGX |
Argenx SE
|
3,136 | $2,290,064 | |
| 7 | MRNA |
Moderna, Inc.
|
43,461 | $2,207,818 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
29,485 | $1,905,615 |
All Filings in GMAB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,537,144 | 57,292 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,268,543 | 73,654 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,430,812 | 79,257 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,088,451 | 52,684 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $827,411 | 42,258 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $724,940 | 34,736 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $430,916 | 17,675 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $484,858 | 19,294 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $591,081 | 19,762 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $451,777 | 14,189 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $535,998 | 15,197 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $646,246 | 17,002 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $600,912 | 15,914 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $660,110 | 15,576 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $451,747 | 14,060 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $292,020 | 8,988 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $288,318 | 7,969 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $213,900 | 5,407 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $234,275 | 5,361 | Shares | Sole | 2021-11-09 | |
| 2021-03-31 | $224,425 | 6,836 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $351,505 | 8,645 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $311,587 | 8,511 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $225,944 | 6,667 | Shares | Sole | 2020-07-27 | |
| No filing history on record for this holder in this stock. | ||||||